Startup Insurers Post Major Losses, With Bright Health in Liquidity Hot Water

Three publicly traded startup insurers all posted losses for the full year 2022, and one firm — Bright Health Group, Inc. — may be on its last legs. A managed care insider tells AIS Health, a division of MMIT, that while Oscar Health, Inc. may have righted the ship and Clover Health Investments Corp. didn’t perform as poorly as expected, Bright is in bad shape.

Bright took in revenue of $551.4 million and posted a net loss of $188.2 million, or negative earnings before interest, taxes, depreciation and amortization (EBITDA) of $108.5 million over 2022, with a medical loss ratio (MLR) of 93.9%. Oscar took in revenue of $3.96 billion against operating expenses of $4.55 billion, posting a net loss of more than $609 million during 2022, with an 85.3% MLR. Clover took in $3.4 billion and reported $298.7 million in negative EBITDA during 2022, with MLR at 91.8%.

0 Comments
© 2024 MMIT
Peter Johnson

Peter Johnson

Peter has been a reporter for nearly a decade. Before joining AIS Health, Peter covered a wide variety of topics in his hometown of Seattle, where he continues to live. Peter’s work has appeared in publications including The Atlantic and The Stranger. Peter attended Colby College.

Related Posts

charts
January 13

Startup Insurer CEOs Talk Profitability Goals at J.P. Morgan Conference

READ MORE
business-meeting
December 16

Oscar Freezes ACA Signups in Florida, Citing ‘Market Exits by Certain Carriers’

READ MORE
stock-charts
November 11

Oscar Has Tough 3Q; Clover Reveals It Will Scale Back ACO REACH Business

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today